Compare with Glenmark Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK LIFE SCIENCES vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GLENMARK LIFE SCIENCES GLENMARK PHARMA GLENMARK LIFE SCIENCES/
GLENMARK PHARMA
 
P/E (TTM) x - 13.5 - View Chart
P/BV x 10.0 2.0 491.0% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 GLENMARK LIFE SCIENCES   GLENMARK PHARMA
EQUITY SHARE DATA
    GLENMARK LIFE SCIENCES
Mar-21
GLENMARK PHARMA
Mar-21
GLENMARK LIFE SCIENCES/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High RsNA573 0.0%   
Low RsNA195 0.0%   
Sales per share (Unadj.) Rs1,923.6387.8 496.0%  
Earnings per share (Unadj.) Rs358.834.4 1,043.5%  
Cash flow per share (Unadj.) Rs392.850.1 784.1%  
Dividends per share (Unadj.) Rs02.50 0.0%  
Avg Dividend yield %NM0.7- 
Book value per share (Unadj.) Rs768.1249.6 307.7%  
Shares outstanding (eoy) m9.80282.17 3.5%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x01.0 0.0%   
Avg P/E ratio x011.2 0.0%  
P/CF ratio (eoy) x07.7 0.0%  
Price / Book Value ratio x01.5 0.0%  
Dividend payout %07.3 0.0%   
Avg Mkt Cap Rs m0108,353 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m1,49123,437 6.4%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m18,852109,439 17.2%  
Other income Rs m8502 1.6%   
Total revenues Rs m18,860109,941 17.2%   
Gross profit Rs m5,91121,289 27.8%  
Depreciation Rs m3344,436 7.5%   
Interest Rs m8753,531 24.8%   
Profit before tax Rs m4,70913,825 34.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,1944,124 28.9%   
Profit after tax Rs m3,5169,701 36.2%  
Gross profit margin %31.419.5 161.2%  
Effective tax rate %25.329.8 85.0%   
Net profit margin %18.68.9 210.4%  
BALANCE SHEET DATA
Current assets Rs m13,99073,596 19.0%   
Current liabilities Rs m12,21442,010 29.1%   
Net working cap to sales %9.428.9 32.6%  
Current ratio x1.11.8 65.4%  
Inventory Days Days27 32.5%  
Debtors Days Days12086 139.8%  
Net fixed assets Rs m5,98067,093 8.9%   
Share capital Rs m20282 6.9%   
"Free" reserves Rs m7,50870,148 10.7%   
Net worth Rs m7,52770,430 10.7%   
Long term debt Rs m038,888 0.0%   
Total assets Rs m19,971140,689 14.2%  
Interest coverage x6.44.9 129.8%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.90.8 121.4%   
Return on assets %22.09.4 233.8%  
Return on equity %46.713.8 339.1%  
Return on capital %74.215.9 467.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m7,87035,753 22.0%   
Fx outflow Rs m3,95512,023 32.9%   
Net fx Rs m3,91523,729 16.5%   
CASH FLOW
From Operations Rs m12,43411,312 109.9%  
From Investments Rs m-12,352-6,752 182.9%  
From Financial Activity Rs m-808-4,418 18.3%  
Net Cashflow Rs m-726278 -260.9%  

Share Holding

Indian Promoters % 82.8 46.7 177.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.5 35.0 24.3%  
FIIs % 8.0 25.9 31.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.2 53.4 32.2%  
Shareholders   280,300 329,870 85.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GLENMARK LIFE SCIENCES With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Sensex Ends 157 Points Higher; ITC, L&T and Asian Paints Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views on News

GLENMARK PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of GLENMARK PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GLENMARK PHARMA. Also includes updates on the valuation of GLENMARK PHARMA.

GLENMARK PHARMA Announces Quarterly Results (1QFY22); Net Profit Up 20.7% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, GLENMARK PHARMA has posted a net profit of Rs 3 bn (up 20.7% YoY). Sales on the other hand came in at Rs 30 bn (up 26.4% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

6 Penny Stocks that Rallied 1,000%+ in One Year(Views On News)

Dec 6, 2021

These penny stocks shed their penny status by surging 1,000% or more in the last one year.

The Biggest Winners and Losers in India's Transition to Electric Vehicles(Profit Hunter)

Nov 26, 2021

How India's EV transition could be a major headwind for the incumbents.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GLENMARK LIFE SCIENCES SHARE PRICE


Dec 9, 2021 (Close)

TRACK GLENMARK LIFE SCIENCES

  • Track your investment in GLENMARK LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GLENMARK LIFE SCIENCES

GLENMARK LIFE SCIENCES 5-YR ANALYSIS

COMPARE GLENMARK LIFE SCIENCES WITH

MARKET STATS